832 Results

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Riaz
    Riaz
  5. Dunn
    Dunn
  6. Wong
    Wong
  7. Ho
    Ho
  8. McBride
    McBride
  9. Shah
    Shah
  10. Tsai
    Tsai

Groups

  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)
  7. Center for Pancreatic Cancer Research (173)
  8. Epidemiology and Biostatistics (162)
  9. Weinberg Fellows (161)
  10. Department of Pathology and Laboratory Medicine (155)
  1. "Head and Neck Service"
Formats
  1. Journal Article (407)
  2. Meeting Abstract (360)
  3. Book Section (20)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (3)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (339)
  3. Nancy Lee (266)
  4. Alan Ho (238)
  5. Nadeem Riaz (159)
  6. Lara Dunn (141)

More People

Years
  1. 2025 (12)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (28)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (219)
  2. Elsevier Inc. (176)
  3. Wiley Blackwell (55)
  4. Oxford University Press (53)
  5. American Association for Cancer Research (46)
  6. Harborside Press (28)

More Publishers

Results (832)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations
    Meeting Abstract

    Ho, A.; Brana, I.; Haddad, R.; Bauman, J.; Bible, K.; Faugeras, L.; Oosting, S.; Wong, D. J.; Ahn, M. J.; Boni, V.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Immunotherapy mythbusters in head and neck cancer: The abscopal effect and pseudoprogression
    Review

    Lauber, K.; Dunn, L.
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save
  • Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy
    Journal Article

    Beckham, T. H.; Leeman, J. E.; Xie, P.; Li, X.; Goldman, D. A.; Zhang, Z.; Sherman, E.; McBride, S.; Riaz, N.; Lee, N.; more...
    British Journal of Cancer (2019)

    Fulltext@MSK | Save
  • A phase 2 efficacy and safety trial of ADU-S100 and pembrolizumab in adults with head and neck cancer
    Meeting Abstract

    Cohen, E.; Ferris, R.; Adkins, D.; Zandberg, D.; Dudek, A.; Mathew, M.; Dunn, L.; Grilley-Olson, J.; Sukari, A.; Redman, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Registrational results of LOXO-292 in patients with RET-altered thyroid cancers
    Meeting Abstract

    Wirth, L.; Sherman, E.; Drilon, A.; Solomon, B.; Robinson, B.; Lorch, J.; McCoach, C.; Patel, J.; Leboulleux, S.; Worden, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti-PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)
    Meeting Abstract

    Rischin, D.; Lim, A. M.; Schmults, C. D.; Khushalani, N. I.; Hughes, B. G.; Schadendorf, D.; Dunn, L. A.; Chang, A. L. S.; Hauschild, A.; Ulrich, C.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • ACCURACY a phase (P) II trial of AL101, a pan-Notch inhibitor, in recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) patients (pts) with Notch activating mutations (Notch act mut): Preliminary safety and efficacy data
    Meeting Abstract

    Ferrarotto, R.; Ho, A.; Wirth, L. J.; Muzaffar, J.; Rodriguez, C.; Dekel, E.; Walker, R. M.; Nadri-Shay, C.; Vergara-Silva, A.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab
    Meeting Abstract

    Yu, Y.; Chen, L.; Riaz, N.; Kang, J.; Tsai, C. J.; Sherman, E. J.; Lee, N. Y.; McBride, S. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx
    Meeting Abstract

    Tchekmedyian, V.; Ho, A. L.; Dunn, L.; Fetten, J. V.; Pfister, D. G.; Lobaugh, S.; Zhang, Z.; Kang, J.; Chen, L.; Riaz, N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save